en · de · es · fr · pt
sr9009-notes.peptides6608.com › News › Analytical Detection And Storage — Research Overview

Analytical Detection And Storage — Research Overview

By Editorial Desk · published 2026-03-17 · last reviewed 2026-04-21 · News

A practical reference on REV-ERB agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-04-21. Anything still debated is marked as such rather than presented as settled.

Analytical Detection and Storage

Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.

Background and Receptor Pharmacology

Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.

Sr9009 at a glance

PropertyValueNotes
Typical storage temperature-20 °C or lowerDesiccated and protected from light
Common analytical methodLC-MS/MSDetects parent drug and metabolites
Solubility classLipophilic; soluble in organic solventsLow aqueous solubility
Molecular weight437.94 g/molCalculated from reported formula
SynonymsSR9009; REV-ERB agonistCode name used in scientific literature

Regulation, Testing, and Storage

Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.

SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.

Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.

Related pages on this site

SR9009 Background and Mechanism

In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.

Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.

Background from the literature

== Division of Health Informatics and Surveillance == The Division of Health Informatics and Surveillance (DHIS) provides leadership and expertise in data, surveillance, and analytics for the CDC and partners with state-of-the-art information systems, capacity building services, and high-quality data to guide public health decisions and actions. These include in case surveillance; syndromic surveillance; and data processing, provisioning, and analytics support the CDC Data Modernization Initiative, health equity, and our critical partners in public health surveillance.

The vaccines are fully synthesized by chemical synthesis and can be treated as chemical entity. With more advanced solid-phase peptide synthesis (SPPS) using automation and microwave techniques, the production of peptides becomes more efficient. The vaccines do not have any biological contamination since they are chemically synthesized. The vaccines are water-soluble and can be kept stable under simple conditions. The peptides can be specially designed for specificity. A single peptide vaccine can be designed to have multiple epitopes to generate immune responses for several diseases. The vaccines only contain a short peptide chain, so they are less like to lead to allergic or auto-immune responses. Disadvantages:

As well as being an optical feature, the Schreger pattern could point towards a micropattern well-designed to prevent crack propagation by dispersing stresses. Additionally, this intricate microstructure lends a strong anisotropy to ivory's mechanical characteristics. Separate hardness measurements on three orthogonal tusk directions indicated that circumferential planes of tusk had up to 25% greater hardness than radial planes of the same specimen. During hardness testing, inelastic and elastic recovery was observed on circumferential planes while the radial planes displayed plastic deformation. This implies that ivory has directional viscoelasticity. These anisotropic properties can be explained by the reinforcement of collagen fibers in the composite oriented along the circumference.

=== Withdrawal === The relatively long half-lives of fluoxetine and its active metabolite norfluoxetine are believed to contribute to a lower risk of antidepressant discontinuation syndrome after stopping treatment, compared with shorter-acting agents such as paroxetine and venlafaxine. Although gradual dose reductions are recommended with antidepressants with shorter half-lives, tapering may not be necessary with fluoxetine. It has been recommended as a treatment option for antidepressant discontinuation syndrome.

==== Upward wealth transfer ==== The Atlantic, CNBC, The New York Times, and Vox argued that the bill would create the largest upward transfer of wealth from the poor to the rich in American history, with Fortune and CNN nicknaming it the "Reverse Robin Hood Bill", Senate Minority Leader Chuck Schumer (D-NY) mockingly called the bill the "We're All Going to Die Act", alluding to comments made by Republican Senator Joni Ernst (R-IA) at a town hall.

Sources: en.wikipedia.org

Further detail

==== Information laundering ==== Generative AI has been noted for its use by state-sponsored propaganda campaigns in information laundering. According to a 2025 report by Graphika, generative AI is used to launder articles from Chinese state media such as China Global Television Network through various social media sites in an attempt to disguise the articles' origin.

=== Migraine === Methylergometrine is sometimes used for both prevention and acute treatment of migraine. It is an active metabolite of methysergide. In the treatment of cluster headaches, methylergometrine has been initiated at a dose of 0.2 mg/day, rapidly increased to 0.2 mg three times per day, and increased to a maximum of 0.4 mg three times per day.

== Environmental record == Since 2000, the company has implemented more than 4,000 greenhouse gas reduction projects. Pfizer has inherited Wyeth's liabilities in the American Cyanamid site in Bridgewater Township, New Jersey, a highly toxic EPA Superfund site. Pfizer has since attempted to remediate this land in order to clean and develop it for future profits and potential public uses. The Sierra Club and the Edison Wetlands Association have opposed the cleanup plan, arguing that the area is subject to flooding, which could cause pollutants to leach. The EPA considers the plan the most reasonable from considerations of safety and cost-effectiveness, arguing that an alternative plan involving trucking contaminated soil off site could expose cleanup workers. The EPA's position is backed by the environmental watchdog group CRISIS. In June 2002, a chemical explosion at the Groton plant injured seven people and caused the evacuation of more than 100 homes in the surrounding area.

== Selected publications == Eaton, D. L., & Groopman, J. D. (Eds.). (1994). The Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance. Academic Press. ISBN 978-0122282553. Ramsdell, H. S., & Eaton, D. L. (1990). Species differences in aflatoxin B1 metabolism in hepatic microsomes and hepatocytes from monkey, rat, mouse, and chicken. Toxicol. Appl. Pharmacol., 105(2), 216–225. Gallagher, E. P., Wienkers, L. C., Stapleton, P. L., Kunze, K. L., & Eaton, D. L. (1994). Role of human microsomal cytochrome P4503A4 and 1A2 in the bioactivation of aflatoxin B1. Cancer Research, 54(1), 101–108. Eaton, D. L., & Bammler, T. K. (1999). Concise review of the glutathione S-transferases and their significance in toxicology. Toxicological Sciences, 49(2), 156–164. National Academies of Sciences, Engineering, and Medicine; Eaton, D. L. et al. (Eds.). (2018). Public Health Consequences of E-Cigarettes. The National Academies Press. ISBN 978-0309468336. Chang, S.-Y., Weber, E. J., Sidorenko, V. S., Chapron, A., Yeung, C. K., Gao, C., Mao, Q., Shen, D., Wang, J., Rosenquist, T. A., Dickman, K. G., Grollman, A. P., *Kelly, E. J., Himmelfarb, J., & Eaton, D. L. (2017). Human liver-kidney microphysiological system for quantum dot toxicity testing and aristolochic acid nephrotoxicity modeling. JCI Insight, 2(6), e91320 Omenn GS & Eaton DL. (2022). The Risk Assessment-Risk Management Paradigm. IN: M. Robson and WA Toscano, Ed. Risk Assessment for Environmental Health, 2nd Edition, Chapter 2, John Wiley & Sons, New York.

=== Identification of de novo emerging sequences === There are two major approaches to the systematic identification of novel genes: genomic phylostratigraphy and synteny-based methods. Both approaches are widely used, individually or in a complementary fashion. To standardise terminology for translated non-canonical ORFs (often implicated in de novo gene studies), a community proposal introduced the term "translons" to denote all translated regions detected by approaches such as ribosome profiling.

Sources: en.wikipedia.org

Background from the literature

The study Does Overfilling Smooth Inflatable Saline-filled Breast Implants Decrease the Deflation Rate? Experience with 4,761 Augmentation Mammaplasty Patients reported that overfilling the prosthetic breast with saline solution (by approx. 10–13%) reduced the rate of rupture-and-deflation to one-point-eighty-three per cent (1.83%) at the eight-year mark after the surgery.

High-dosage treatment of creatine has been shown to worsen symptoms of myalgia (muscle pain). A ketogenic diet has demonstrated beneficial for McArdle disease (GSD-V) as ketones readily convert to acetyl CoA for oxidative phosphorylation, whereas free fatty acids take a few minutes to convert into acetyl CoA. Ketones are a part of fat metabolism, the ketones can act as the main fuel before fatty acid catabolism takes over (second wind), during which the ketones would act as a supplementary fuel alongside the fatty acids to produce adenosine triphosphate (ATP) by oxidative phosphorylation.

Harald Pedersen (born 1878 in Øster Hurup – died 1966) was a Danish engineer and industrialist who, together with his brother Thorvald Pedersen, co-founded the pharmaceutical company Novo Terapeutisk Laboratorium in 1925, predecessor of Novo Nordisk. Their work played a key role in the early Danish insulin industry.

=== Upper eyelid === The upper eyelid contains medial and central fat compartments and is elevated by the levator palpebrae superioris muscle. The eyelid crease is formed by attachments of the levator aponeurosis to the skin. Aging changes include excess skin and fat prominence.

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 measured?

Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.

How should SR9009 be stored?

Research samples are typically kept frozen, desiccated, and protected from light. Stock solutions are often aliquoted to reduce freeze-thaw cycles.

What purity methods are used?

High-performance liquid chromatography and nuclear magnetic resonance are standard for purity and identity. Mass spectrometry confirms molecular weight.

What is SR9009?

SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.

Network